Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: A membrane proteomics approach

Cancer Letters

Volumn 263, Issue 2, 2008, Pages 243-252

  Seyfried, Nicholas T ^a   Huysentruyt, Leanne C ^b   Atwood III, James A ^a   Xia, Qiangwei ^c   Seyfried, Thomas N ^b   Orlando, Ron ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b BOSTON COLLEGE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Biomarker; Inflammation; Invasion; Tumor

Indexed keywords

BIOLOGICAL MARKER; CHRONDROITIN SULFATE PROTEOGLYCAN 4; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 2; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; MEMBRANE PROTEIN; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER CELL CULTURE; DOWN REGULATION; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; UPREGULATION;

ANIMALS; ANTIGENS; ASTROCYTOMA; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL LINEAGE; CHROMATOGRAPHY, LIQUID; MEMBRANE PROTEINS; MICE; PROTEINS; PROTEOGLYCANS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 41649119924     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.01.007     Document Type: Article

References (45)

1. Zhang J., and Li L. BMP signaling and stem cell regulation. Dev Biol. 284 (2005) 1-11
2. Sanai N., Alvarez-Buylla A., and Berger M.S. Neural stem cells and the origin of gliomas. N Engl J Med. 353 (2005) 811-822
3. McKay R. Stem cell biology and neurodegenerative disease. Philos. Trans. R. Soc. B Biol. Sci. 359 (2004) 851-856
4. Emsley J.G., Mitchell B.D., Kempermann G., and Macklis J.D. Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog. Neurobiol. 75 (2005) 321-341
5. Bjerkvig R., Tysnes B.B., Aboody K.S., Najbauer J., and Terzis A.J. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat. Rev. Cancer 5 (2005) 899-904
6. Bello L., Giussani C., Carrabba G., Pluderi M., Costa F., and Bikfalvi A. Angiogenesis and invasion in gliomas. Cancer Treat. Res. 117 (2004) 263-284
7. Seyfried T.N. Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells. Perspect. Biol. Med. 44 (2001) 263-282
8. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
9. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
10. Aebersold R., and Goodlett D.R. Mass spectrometry in proteomics. Chem. Rev. 101 (2001) 269-295
11. Wu C.C., and Yates III J.R. The application of mass spectrometry to membrane proteomics. Nat. Biotechnol. 21 (2003) 262-267
12. Seyfried T.N., el-Abbadi M., and Roy M.L. Ganglioside distribution in murine neural tumors. Mol. Chem. Neuropathol. 17 (1992) 147-167
13. Alliot F., and Pessac B. Astrocytic cell clones derived from established cultures of 8-day postnatal mouse cerebella. Brain Res. 306 (1984) 283-291
14. Miguet L., Pacaud K., Felden C., Hugel B., Martinez M.C., Freyssinet J.M., Herbrecht R., Potier N., van Dorsselaer A., and Mauvieux L. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 6 (2006) 153-171
15. Wu C.C., MacCoss M.J., Howell K.E., and Yates III J.R. A method for the comprehensive proteomic analysis of membrane proteins. Nat. Biotechnol. 21 (2003) 532-538
16. Schagger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
17. Pedrioli P.G., Eng J.K., Hubley R., Vogelzang M., Deutsch E.W., Raught B., Pratt B., Nilsson E., Angeletti R.H., Apweiler R., Cheung K., Costello C.E., Hermjakob H., Huang S., Julian R.K., Kapp E., McComb M.E., Oliver S.G., Omenn G., Paton N.W., Simpson R., Smith R., Taylor C.F., Zhu W., and Aebersold R. A common open representation of mass spectrometry data and its application to proteomics research. Nat. Biotechnol. 22 (2004) 1459-6146
18. Weatherly D.B., Astwood III J.A., Minning T.A., Cavola C., Tarleton R.L., and Orlando R. A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Mol. Cell. Proteomics 4 (2005) 762-772
19. Krogh A., Larsson B., von Heijne G., and Sonnhammer E.L.L. Predicting transmembrane protein topology with a hidden markov model: application to complete genomes. J. Mol. Biol. 305 (2001) 567-580
20. Xia Q., Wang T., Park Y., Lamont R.J., and Hackett M. Differential quantitative proteomics of Porphyromonas gingivalis by linear ion trap mass spectrometry: non-label methods comparison, q-values and LOWESS curve fitting. Int. J. Mass Spectrom. 259 (2007) 105-116
21. Abate L.E., Mukherjee P., and Seyfried T.N. Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma. J. Neurochem. 98 (2006) 1973-1984
22. Andreu P., Colnot S., Godard C., Laurent-Puig P., Lamarque D., Kahn A., Perret C., and Romagnolo B. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 66 (2006) 1949-1955
23. Perkins D.N., Pappin D.J., Creasy D.M., and Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 (1999) 3551-3567
24. Leger O., Johnson-Leger C., Jackson E., Coles B., and Dean C. The chondroitin sulfate proteoglycan NG2 is a tumour-specific antigen on the chemically induced rat chondrosarcoma HSN. Int. J. Cancer. 58 (1994) 700-705
25. Stallcup W.B. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 31 (2002) 423-435
26. Nishiyama A., Watanabe M., Yang Z., and Bu J. Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J. Neurocytol. 31 (2002) 437-455
27. Chekenya M., and Pilkington G.J. NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. J. Neurocytol. 31 (2002) 507-521
28. Fukushi J., Makagiansar I.T., and Stallcup W.B. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol. Biol. Cell 15 (2004) 3580-3590
29. Wen Y., Makagiansar I.T., Fukushi J., Liu F.T., Fukuda M.N., and Stallcup W.B. Molecular basis of interaction between NG2 proteoglycan and galectin-3. J. Cell. Biochem. 98 (2006) 115-127
30. Camby I., Decaestecker C., Lefranc F., Kaltner H., Gabius H.J., and Kiss R. Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern. Biochem. Biophys. Res. Commun. 335 (2005) 27-35
31. Camby I., Le Mercier M., Lefranc F., and Kiss R. Galectin-1: a small protein with major functions. Glycobiology 16 (2006) 137R-157R
32. Lewin A.R., Reid L.E., McMahon M., Stark G.R., and Kerr I.M. Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 199 (1991) 417-423
33. Tanaka S.S., Yamaguchi Y.L., Tsoi B., Lickert H., and Tam P.P. IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev. Cell 9 (2005) 745-756
34. Cox B., Kislinger T., Wigle D.A., Kannan A., Brown K., Okubo T., Hogan B., Jurisica I., Frey B., Rossant J., and Emili A. Integrated proteomic and transcriptomic profiling of mouse lung development and Nmyc target genes. Mol. Syst. Biol. 3 (2007) 109
35. Gurkan C., Koulov A.V., and Balch W.E. An evolutionary perspective on eukaryotic membrane trafficking. Adv. Exp. Med. Biol. 607 (2007) 73-83
36. Blasius A.L., Giurisato E., Cella M., Schreiber R.D., Shaw A.S., and Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177 (2006) 3260-3265
37. Ohtomo T., Sugamata Y., Ozaki Y., Ono K., Yoshimura Y., Kawai S., Koishihara Y., Ozaki S., Kosaka M., Hirano T., and Tsuchiya M. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem. Biophys. Res. Commun. 258 (1999) 583-591
38. Einav U., Tabach Y., Getz G., Yitzhaky A., Ozbek U., Amariglio N., Izraeli S., Rechavi G., and Domany E. Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer. Oncogene 24 (2005) 6367-6375
39. Daniels T.R., Delgado T., Helguera G., and Penichet M.L. The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells. Clin. Immunol. 121 (2006) 159-176
40. Daniels T.R., Delgado T., Rodriguez J.A., Helguera G., and Penichet M.L. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121 (2006) 144-158
41. Liu F., Park P.J., Lai W., Maher E., Chakravarti A., Durso L., Jiang X., Yu Y., Brosius A., Thomas M., Chin L., Brennan C., DePinho R.A., Kohane I., Carroll R.S., Black P.M., and Johnson M.D. A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res. 66 (2006) 10815-10823
42. Pilkington G.J. Cancer stem cells in the mammalian central nervous system. Cell Prolif. 38 (2005) 423-433
43. Engelhard V.H., Altrich-Vanlith M., Ostankovitch M., and Zarling A.L. Post-translational modifications of naturally processed MHC-binding epitopes. Curr. Opin. Immunol. 18 (2006) 92-97
44. Recht L., Torres C.O., Smith T.W., Raso V., and Griffin T.W. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J. Neurosurg. 72 (1990) 941-945
45. Wiranowska M., Ladd S., Smith S.R., and Gottschall P.E. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. Brain Cell Biol. 35 (2006) 159-172